Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rotavirus VP4 is the spike-forming outer capsid protein that mediates attachment of the non-enveloped rotavirus virion to host epithelial cell receptors and drives membrane penetration during infectious entry[1][2][5]. It requires cleavage by enteric trypsin-like proteases at conserved arginine residues (R231, R241, R247) to generate VP8* (N-terminal receptor-binding head) and VP5* (C-terminal stalk with membrane interaction domains), enabling conformational changes from an upright to a reversed state that exposes hydrophobic loops for membrane insertion[1][2][3]. VP4 trimers project from the virion surface, anchored by interactions with VP6 and VP7, and undergo protease-dependent rearrangement critical for uncoating and infectivity; mutations like R241T reduce trypsin sensitivity but can be compensated for full replication[1][2]. The P1A serotype corresponds to the P genotype common in human rotaviruses, influencing host tropism via glycan binding (e.g., histo-blood group antigens)[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rotavirus VP4 (P genotype) (VP4).